ResearcherThe University of OsakaActive in the last 2 years
Kenta Furukawa
Matched on ORCID iD 0000-0002-9572-8111; OpenAlex author ID A5103214982. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2015: 2 papers · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers
Papers 6
- Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer. First author DOI 10.1038/s41598-024-60936-4↗
- Portal vein wedge resection and patch venoplasty with autologous vein grafts for hepatobiliary-pancreatic cancer. First author DOI 10.1186/s40792-024-01823-y↗
- [A Case Report-A Successful Case of Distal Pancreatectomy with En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Cancer with an Aberrant Right Hepa… Co-author PMID 36927906↗
- A practical approach to pancreatic cancer immunotherapy using resected tumor lysate vaccines processed to express α-gal epitopes. Co-author DOI 10.1371/journal.pone.0184901↗
- Clinicopathological Significance of Leucine-Rich α2-Glycoprotein-1 in Sera of Patients With Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000000205↗
- Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic cancer stem cells. Co-author DOI 10.3892/ijo.2014.2717↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tadafumi Asaoka · 4 shared papers, 2017–2024 · strength 0.60
- Paper Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer. DOI 10.1038/s41598-024-60936-4↗
- Paper Portal vein wedge resection and patch venoplasty with autologous vein grafts for hepatobiliary-pancreatic cancer. DOI 10.1186/s40792-024-01823-y↗
- Paper [A Case Report-A Successful Case of Distal Pancreatectomy with En Bloc Celiac Axis Resection for Locally Advanced Pancr… PMID 36927906↗
- Manabu Mikamori · 3 shared papers, 2023–2024 · strength 0.55
- Paper Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer. DOI 10.1038/s41598-024-60936-4↗
- Paper Portal vein wedge resection and patch venoplasty with autologous vein grafts for hepatobiliary-pancreatic cancer. DOI 10.1186/s40792-024-01823-y↗
- Paper [A Case Report-A Successful Case of Distal Pancreatectomy with En Bloc Celiac Axis Resection for Locally Advanced Pancr… PMID 36927906↗
- Masahiro Tanemura · 4 shared papers, 2015–2024 · strength 0.35
- Paper Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer. DOI 10.1038/s41598-024-60936-4↗
- Paper A practical approach to pancreatic cancer immunotherapy using resected tumor lysate vaccines processed to express α-gal… DOI 10.1371/journal.pone.0184901↗
- Paper Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic … DOI 10.3892/ijo.2014.2717↗
- Hidetoshi Eguchi · 4 shared papers, 2015–2024 · strength 0.35
- Paper Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer. DOI 10.1038/s41598-024-60936-4↗
- Paper A practical approach to pancreatic cancer immunotherapy using resected tumor lysate vaccines processed to express α-gal… DOI 10.1371/journal.pone.0184901↗
- Paper Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic … DOI 10.3892/ijo.2014.2717↗
- Satoshi Hyuga · 2 shared papers, 2023–2024 · strength 0.34
- Tomofumi Ohashi · 2 shared papers, 2023–2024 · strength 0.34
- Tsunekazu Mizushima · 2 shared papers, 2023–2024 · strength 0.34
- Daisaku Yamada · 2 shared papers, 2017–2024 · strength 0.27
- Daiki Marukawa · 1 shared paper, 2024 · strength 0.21
- Yuichiro Doki · 3 shared papers, 2015–2017 · strength 0.14
- Paper A practical approach to pancreatic cancer immunotherapy using resected tumor lysate vaccines processed to express α-gal… DOI 10.1371/journal.pone.0184901↗
- Paper Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic … DOI 10.3892/ijo.2014.2717↗
- Paper Clinicopathological Significance of Leucine-Rich α2-Glycoprotein-1 in Sera of Patients With Pancreatic Cancer. DOI 10.1097/mpa.0000000000000205↗
- Hiroaki Nagano · 3 shared papers, 2015–2017 · strength 0.14
- Paper A practical approach to pancreatic cancer immunotherapy using resected tumor lysate vaccines processed to express α-gal… DOI 10.1371/journal.pone.0184901↗
- Paper Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic … DOI 10.3892/ijo.2014.2717↗
- Paper Clinicopathological Significance of Leucine-Rich α2-Glycoprotein-1 in Sera of Patients With Pancreatic Cancer. DOI 10.1097/mpa.0000000000000205↗
- Eiji Miyoshi · 3 shared papers, 2015–2017 · strength 0.14
- Paper A practical approach to pancreatic cancer immunotherapy using resected tumor lysate vaccines processed to express α-gal… DOI 10.1371/journal.pone.0184901↗
- Paper Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic … DOI 10.3892/ijo.2014.2717↗
- Paper Clinicopathological Significance of Leucine-Rich α2-Glycoprotein-1 in Sera of Patients With Pancreatic Cancer. DOI 10.1097/mpa.0000000000000205↗
- Hirofumi Akita · 2 shared papers, 2015 · strength 0.08
- Paper Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic … DOI 10.3892/ijo.2014.2717↗
- Paper Clinicopathological Significance of Leucine-Rich α2-Glycoprotein-1 in Sera of Patients With Pancreatic Cancer. DOI 10.1097/mpa.0000000000000205↗
- Tsukasa Tanida · 2 shared papers, 2015 · strength 0.08
- Paper Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic … DOI 10.3892/ijo.2014.2717↗
- Paper Clinicopathological Significance of Leucine-Rich α2-Glycoprotein-1 in Sera of Patients With Pancreatic Cancer. DOI 10.1097/mpa.0000000000000205↗
- Tetsuji Naka · 1 shared paper, 2015 · strength 0.04
- Yoshito Tomimaru · 1 shared paper, 2015 · strength 0.04
- Shinichiro Shinzaki · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.